Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$552M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$519M |
| 3 |
Microsoft
MSFT
|
+$417M |
| 4 |
Apple
AAPL
|
+$376M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.4B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$396M |
| 3 |
Estee Lauder
EL
|
+$326M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$302M |
| 5 |
S&P Global
SPGI
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.93% |
| 2 | Financials | 5.77% |
| 3 | Consumer Discretionary | 5.25% |
| 4 | Healthcare | 5.08% |
| 5 | Communication Services | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
PUT
Under Armour
UAA
$2.89B
| $1.17M | ﹤0.01% |
120,000
+600
| +0.5% | +$5.69K |
|
|
ICPT
3352
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.17M | ﹤0.01% |
24,400
+9,600
| +65% | +$742K |
|
|
CSOD
3353
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.17M | ﹤0.01% |
30,340
-5,014
| -14% | -$176K |
|
3354
Cytokinetics
CYTK
$10.4B
| $1.17M | ﹤0.01% |
49,543
+7,941
| +19% | +$149K |
|
3355
Brookfield Renewable
BEP
$10.2B
| $1.17M | ﹤0.01% |
45,865
-20,777
| -31% | -$522K |
|
3356
iShares US Financials ETF
IYF
$4.62B
| $1.17M | ﹤0.01% |
21,176
-278
| -1% | -$14.8K |
|
3357
Encore Capital Group
ECPG
$2.06B
| $1.17M | ﹤0.01% |
34,111
-3,499
| -9% | -$104K |
|
|
FEAC.U
3358
DELISTED
Flying Eagle Acquisition Corp. Units, each consisting of one share of Class A common stock and one-f
FEAC.U
| $1.17M | ﹤0.01% |
100,000
| – | – |
|
3359
PUT
Bread Financial
BFH
$4.48B
| $1.16M | ﹤0.01% |
32,327
-68,540
| -68% | -$2.44M |
|
3360
State Street SPDR S&P Global Dividend ETF
WDIV
$280M
| $1.16M | ﹤0.01% |
22,093
+19,091
| +636% | +$984K |
|
3361
PUT
Canadian Natural Resources
CNQ
$96.7B
| $1.16M | ﹤0.01% |
137,222
+1,225
| +0.9% | +$9.89K |
|
3362
Crocs
CROX
$6.47B
| $1.16M | ﹤0.01% |
31,555
+9,616
| +44% | +$254K |
|
3363
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.72B
| $1.16M | ﹤0.01% |
38,349
+534
| +1% | +$15.3K |
|
3364
Spectrum Brands
SPB
$2.04B
| $1.16M | ﹤0.01% |
25,282
-33,111
| -57% | -$1.41M |
|
3365
ABM Industries
ABM
$2.86B
| $1.16M | ﹤0.01% |
31,846
-2,552
| -7% | -$82.7K |
|
3366
Globus Medical
GMED
$11.1B
| $1.16M | ﹤0.01% |
24,215
-4,814
| -17% | -$232K |
|
3367
PUT
Tilray
TLRY
$632M
| $1.16M | ﹤0.01% |
16,250
+2,430
| +18% | +$196K |
|
3368
CALL
H&R Block
HRB
$5.73B
| $1.15M | ﹤0.01% |
80,800
-41,800
| -34% | -$661K |
|
3369
PUT
Apollo Global Management
APO
$74.6B
| $1.15M | ﹤0.01% |
23,100
-8,200
| -26% | -$360K |
|
3370
PUT
Mattel
MAT
$4.32B
| $1.15M | ﹤0.01% |
119,200
-47,900
| -29% | -$435K |
|
|
TXNM
3371
TXNM Energy Inc
TXNM
$5.94B
| $1.15M | ﹤0.01% |
29,978
-856
| -3% | -$34.2K |
|
3372
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $1.15M | ﹤0.01% |
12,026
-4,184
| -26% | -$384K |
|
3373
Coca-Cola Femsa
KOF
$22.5B
| $1.15M | ﹤0.01% |
26,225
-50
| -0.2% | -$2.1K |
|
3374
Ingevity
NGVT
$2.52B
| $1.15M | ﹤0.01% |
21,849
+447
| +2% | +$21.2K |
|
|
PGRE
3375
DELISTED
Paramount Group
PGRE
| $1.15M | ﹤0.01% |
148,726
+49,570
| +50% | +$418K |
|
Similar funds
Citigroup's Q2 2020 Portfolio in Review
As of Q2 2020, Citigroup held 7,909 positions worth $128B, up 16% from $111B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citigroup withdrew a net $7.44B in Q2 2020, closing 313 positions and reducing 3,200 holdings. Its most notable exit was Allergan plc, an estimated $1.4B position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 6.7% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Technology Momentum ETF worth $156M.
- Citigroup's largest Q2 2020 buy was Invesco Dorsey Wright Technology Momentum ETF: 4,800,363 shares worth $156M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $552M increase.
- Citigroup's biggest Q2 2020 reduction was Alphabet (Google) Class A, cutting an estimated $396M.
- Citigroup fully exited Allergan plc in Q2 2020, selling an estimated $1.4B.
- Citigroup's ten largest holdings make up 23% of its $128B portfolio in Q2 2020.
- Citigroup opened 257 new positions and closed 313 in Q2 2020.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $128B.
Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.